|
Mar 31
|
1 Top Growth Stock to Buy and Hold Forever
|
|
Mar 31
|
2 Rock-Solid Growth Stocks to Buy Right Now and Hold for at Least 5 Years
|
|
Mar 30
|
3 Unstoppable Stocks to Buy Hand Over Fist in April
|
|
Mar 28
|
Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why
|
|
Mar 26
|
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
|
|
Mar 25
|
Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts
|
|
Mar 25
|
Vertex (VRTX) Continues to Diversify Beyond CF Franchise
|
|
Mar 22
|
Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development
|
|
Mar 21
|
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
|
Mar 20
|
3 Biopharma Stocks Predicted to Soar in Q2 2024
|
|
Mar 19
|
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
|
|
Mar 17
|
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
|
|
Mar 17
|
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
|
|
Mar 17
|
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
|
|
Mar 16
|
Is It Too Late to Buy CRISPR Therapeutics Stock?
|
|
Mar 13
|
Q4 2023 MaxCyte Inc Earnings Call
|
|
Mar 12
|
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know
|
|
Mar 9
|
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
|
|
Mar 6
|
Vertex (VRTX) Down 0.2% Since Last Earnings Report: Can It Rebound?
|
|
Mar 5
|
GSK vs. VRTX: Which Stock Is the Better Value Option?
|